Cambrian Bio

Cambrian Bio

Biotechnology, Us, New York, 11217, United States, 11-50 Employees

cambrianbio.com

  • facebook
  • twitter
  • LinkedIn

Who is CAMBRIAN BIO

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics des...

Read More

map
  • New York New York 11217 Us, New York, New York, 11217, United States Headquarters: New York New York 11217 Us, New York, New York, 11217, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from CAMBRIAN BIO

Cambrian Bio Org Chart and Mapping

Employees

Prashant Vijay

Vice President of New Projects

Ryan White

Senior Information Technology Manager

Diana Brassard

Senior Director R&D Project Manager

Erik Schneider

Director, Business Development

Juliette Han

Chief Operating Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cambrian Bio

Answer: Cambrian Bio's headquarters are located at Us, New York, 11217, United States

Answer: Cambrian Bio's official website is https://cambrianbio.com

Answer: Cambrian Bio's revenue is $5 Million to $10 Million

Answer: Cambrian Bio has 11-50 employees

Answer: Cambrian Bio is in Biotechnology

Answer: Cambrian Bio contact info: Phone number: Website: https://cambrianbio.com

Answer: Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to prevent diseases and lengthen healthspanthe period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age. To date, we have more than a dozen programs (PipeCos) in our pipeline, including Amplifier Therapeutics (developing a peripherally restricted pan-AMPK activator for the treatment of cardiometabolic diseases), Tornado Therapeutics (developing safer, more effective mTOR inhibitors for extended healthspan), and our latest addition, Telos Biotech (enhancing cell therapies to overcome senescence and exhaustion). We also has programs focused on Womens Health and Aging (Oviva Therapeutics), Fibrosis (Isterian Biotech), and cellular engineering (Vita Therapeutics).

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access